These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32224336)

  • 1. Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation.
    Jadhavar PS; Patel KI; Dhameliya TM; Saha N; Vaja MD; Krishna VS; Sriram D; Chakraborti AK
    Bioorg Chem; 2020 Jun; 99():103774. PubMed ID: 32224336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.
    Dhameliya TM; Patel KI; Tiwari R; Vagolu SK; Panda D; Sriram D; Chakraborti AK
    Bioorg Chem; 2021 Feb; 107():104538. PubMed ID: 33349456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.
    Jadhavar PS; Dhameliya TM; Vaja MD; Kumar D; Sridevi JP; Yogeeswari P; Sriram D; Chakraborti AK
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2663-9. PubMed ID: 27095514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzo[d]thiazole-2-carbanilides as new anti-TB chemotypes: Design, synthesis, biological evaluation, and structure-activity relationship.
    Dhameliya TM; Tiwari R; Banerjee A; Pancholia S; Sriram D; Panda D; Chakraborti AK
    Eur J Med Chem; 2018 Jul; 155():364-380. PubMed ID: 29902722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Sulfonamidophosphonates as new anti-mycobacterial chemotypes: Design, development of synthetic methodology, and biological evaluation.
    Bhagat S; Supriya M; Pathak S; Sriram D; Chakraborti AK
    Bioorg Chem; 2019 Feb; 82():246-252. PubMed ID: 30391855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel N' (4-aryloxybenzylidene)- 1H-benzimidazole-2 carbohydrazide derivatives as anti-tubercular agents.
    Siddiki AA; Bairwa VK; Telvekar VN
    Comb Chem High Throughput Screen; 2014; 17(7):630-8. PubMed ID: 24625232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro antitubercular activity of pyridine analouges against the resistant Mycobacterium tuberculosis.
    Patel H; Chaudhari K; Jain P; Surana S
    Bioorg Chem; 2020 Sep; 102():104099. PubMed ID: 32711084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antituberculosis: synthesis and antimycobacterial activity of novel benzimidazole derivatives.
    Keng Yoon Y; Ashraf Ali M; Choon TS; Ismail R; Chee Wei A; Suresh Kumar R; Osman H; Beevi F
    Biomed Res Int; 2013; 2013():926309. PubMed ID: 24381946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
    Hwang JM; Oh T; Kaneko T; Upton AM; Franzblau SG; Ma Z; Cho SN; Kim P
    J Nat Prod; 2013 Mar; 76(3):354-67. PubMed ID: 23360475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1H-Benzo[d]imidazoles and 3,4-dihydroquinazolin-4-ones: Design, synthesis and antitubercular activity.
    Macchi FS; Pissinate K; Villela AD; Abbadi BL; Rodrigues-Junior V; Nabinger DD; Altenhofen S; Sperotto N; da Silva Dadda A; Subtil FT; de Freitas TF; Erhart Rauber AP; Borsoi AF; Bonan CD; Bizarro CV; Basso LA; Santos DS; Machado P
    Eur J Med Chem; 2018 Jul; 155():153-164. PubMed ID: 29885576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents.
    Fan YL; Wu JB; Ke X; Huang ZP
    Bioorg Med Chem Lett; 2018 Oct; 28(18):3064-3066. PubMed ID: 30119957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
    Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
    Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and in vitro anti-mycobacterial evaluation of gatifloxacin-1H-1,2,3-triazole-isatin hybrids.
    Xu Z; Zhang S; Song X; Qiang M; Lv Z
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3643-3646. PubMed ID: 28720502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, development of new synthetic methodology, and biological evaluation of substituted quinolines as new anti-tubercular leads.
    Tanwar B; Kumar A; Yogeeswari P; Sriram D; Chakraborti AK
    Bioorg Med Chem Lett; 2016 Dec; 26(24):5960-5966. PubMed ID: 27839684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and molecular docking studies of imidazole and benzimidazole linked ethionamide derivatives as inhibitors of InhA and antituberculosis agents.
    Raghu MS; Pradeep Kumar CB; Yogesh Kumar K; Prashanth MK; Alshahrani MY; Ahmad I; Jain R
    Bioorg Med Chem Lett; 2022 Mar; 60():128604. PubMed ID: 35123004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and evaluation of novel 2,5,6-trisubstituted benzimidazoles targeting FtsZ as antitubercular agents.
    Park B; Awasthi D; Chowdhury SR; Melief EH; Kumar K; Knudson SE; Slayden RA; Ojima I
    Bioorg Med Chem; 2014 May; 22(9):2602-12. PubMed ID: 24726304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzimidazole-based compounds kill Mycobacterium tuberculosis.
    Gong Y; Somersan Karakaya S; Guo X; Zheng P; Gold B; Ma Y; Little D; Roberts J; Warrier T; Jiang X; Pingle M; Nathan CF; Liu G
    Eur J Med Chem; 2014 Mar; 75():336-53. PubMed ID: 24556148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.